Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling.

Batzilla A, Lu J, Kivioja J, Putzker K, Lewis J, Zenz T, Huber W

PLoS computational biology, 2022

doi:10.1371/journal.pcbi.1010438.